scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1440-1746.2002.02876.X |
P698 | PubMed publication ID | 12453280 |
P2093 | author name string | Hiroshi Suzuki | |
Katsuaki Tanaka | |||
Yasuo Endo | |||
Yuzuru Sato | |||
Jun Miyazaki | |||
Tomoyuki Umeda | |||
Makoto Kako | |||
Shigeki Hayashi | |||
Makoto Yoshiba | |||
Toshiro Tango | |||
Keiji Mitamura | |||
Naoaki Hashimoto | |||
Norimasa Hayashida | |||
Shogo Iwabuchi | |||
Kazuhiko Miyake | |||
Yusei Ikeda | |||
Naoya Funaki | |||
Toshiaki Tomi | |||
Yasuhiko Ota | |||
P2860 | cites work | The long term efficacy of glycyrrhizin in chronic hepatitis C patients. | Q53444006 |
P433 | issue | 11 | |
P304 | page(s) | 1198-1204 | |
P577 | publication date | 2002-11-01 | |
P1433 | published in | Journal of Gastroenterology and Hepatology | Q15764401 |
P1476 | title | Efficacy of Stronger Neo-Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis | |
P478 | volume | 17 |
Q36948453 | Antiviral effects of Glycyrrhiza species |
Q38376367 | Compound glycyrrhizin plus conventional therapy for psoriasis vulgaris: a systematic review and meta-analysis of randomized controlled trials |
Q36119173 | Development of antiviral therapy for severe acute respiratory syndrome. |
Q35825117 | Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients |
Q52641388 | Glycyrrhizin Suppresses the Growth of Human NSCLC Cell Line HCC827 by Downregulating HMGB1 Level. |
Q45353010 | Guidelines for the Management of Hepatitis C Virus Infection: First edition, May 2012, The Japan Society of Hepatology |
Q36269281 | Herbal medicines for liver diseases |
Q46812715 | Insulin independence of unstable diabetic patient after single living donor islet transplantation |
Q34186196 | Recent advances in herbal medicine for treatment of liver diseases |
Q34554574 | The use of selected nutrition supplements and complementary and alternative medicine in liver disease |
Q80194076 | Yo Jyo Hen Shi Ko (YHK) improves transaminases in nonalcoholic steatohepatitis (NASH): a randomized pilot study |
Search more.